MedPath

Estimation of Pulmonary Capillary Blood Volume in Pre- and Postcapillary Pulmonary Hypertension

Completed
Conditions
Hypertension Pulmonary
Interventions
Other: assessment of DLNO and DLCO
Registration Number
NCT02789449
Lead Sponsor
Medical University of Graz
Brief Summary

The aim of the study is to investigate the role of the non-invasive assessment of nitric oxyde (NO) diffusion capacity (DLNO) in the differential diagnosis of different forms of pulmonary hypertension (PH). DLNO alone and in combination with the measurement of carbon monoxide (CO) diffusion capacity (DLCO) may help to differentiate between pre- and postcapillary forms of pulmonary hypertension. This hypothesis is based on the fact that NO has a much higher affinity to hemoglobin as compared to CO and may therefore its decrease may more specifically identify the limiting factors between the alveolar space and the lung capillaries including left heart failure (cardiac edema).

As there are no available published data yet to answer this question investigators aim to perform a small pilot study. The results of this study may allow the planning of a prospective study.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
17
Inclusion Criteria
  • patients undergoing right heart catheterization
  • patients with clear precapillary PH (PAWP<12mmHg) or clear postcapillary PH (PAWP>18mmHg)
  • signed informed consent
Exclusion Criteria
  • patients unable to perform the DLCO test

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
postcapillaryassessment of DLNO and DLCOpatients with PH and PAWP\>18mmHg
precapillaryassessment of DLNO and DLCOpatients with PH and PAWP\<12mmHg
Primary Outcome Measures
NameTimeMethod
Difference in DLNO (in mmol/min/kPa) between the two predefined groups (patients with clear precapillary PH (PAWP<12mmHg) vs. clear postcapillary PH (PAWP>18mmHg))one hour
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Medical University Graz, Division of Pulmonology

🇦🇹

Graz, Steiermark, Austria

© Copyright 2025. All Rights Reserved by MedPath